Characteristics of patients with congenital neutropenia
Subject . | Age (y) . | Gender . | ANC1-1/ mm1-3 . | AMC1-2/ mm1-3 . | Platelets1-3× 101-3/mm1-3 . | HCT1-4% . | Bone marrow evaluations1-5 . | Elastase mutations . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mblast % . | Promyelo % . | Myelo % . | Meta % . | B/Poly % . | Exon/intron . | Nucleotide1-6 . | Effect on protein1-7 . | |||||||
1 | 4 | M | 0 | 2943 | 558 | 36 | Severe maturation arrest | Exon 2 | G34010A | A28T | ||||
2 | 13 | M | 0 | 1891 | 348 | 32 | 2 | 5 | 23 | 7 | 2 | Exon 2 | T34020C | I31T |
3 | 15 | F | 106 | 1484 | 349 | 36 | 0 | 6 | 0 | 0 | 1 | Exon 2 | T34052A | C42S |
4 | 3 | F | 97 | 2928 | 547 | 30 | Arrest at myelocyte, very few mature neutrophils | Exon 3 | G34371A | V72M | ||||
5 | 8 | F | 126 | 1071 | 513 | 27 | 0 | 5 | 7 | 0 | 0 | Exon 3 | G34371A | V72M |
6 | 11 | M | 0 | 5372 | 576 | 29 | 0 | 7 | 1 | 0 | 1 | Exon 4 | C15823T | S97L |
7 | 3 | F | 79 | 2196 | 546 | 30 | 0 | 2 | 7 | 2 | 0 | Exon 4 | C15862T | P110L |
8 | 15 | F | 159 | 599 | 403 | 37 | 0 | 21 | 19 | 0 | 0 | Exon 4 | C15862T | P110L |
9 | 25 | M | 215 | 320 | 214 | 39 | 3 | 8 | 21 | 11 | 4 | Exon 4 | C15862T | P110L |
10 | 33 | F | 220 | 740 | 227 | 32 | 0 | 4 | 6 | 2 | 4 | Exon 4 | C15862T | P110L |
11 | 14 | M | 96 | 1088 | 320 | 25 | 3 | 11 | 2 | 0 | 0 | Exon 4 | ins5T16063 | delV161-F170 +2fs |
12 | 18 | F | 33 | 990 | 483 | 36 | 0 | 10 | 1 | 2 | 0 | Exon 4 | del15995-16018 | delV145-C152 |
13 | 4 | F | 0 | 3943 | 639 | 43 | Not done | Exon 5 | G16268T | G181V | ||||
14 | 10 | F | 0 | 1610 | 650 | 34 | 0 | 9 | 0 | 0 | 0 | Exon 5 | G16279A | G185R |
15 | 0.4 | M | 34 | 3041 | 272 | 39 | 3 | 1 | 1 | 0 | 1 | Exon 5 | G16300T | G192Stop |
16 | 4 | M | 318 | 504 | 534 | 35 | 1 | 10 | 26 | 15 | 6 | Exon 5 | C16313A | S196Stop |
17 | 3 | F | 200 | 4300 | 722 | 26 | Not done | Exon 5 | C16323A | Y199Stop | ||||
18 | 5 | M | 0 | 1797 | 345 | 34 | Not done | Exon 5 | delC16324 | Minus 1fs | ||||
19 | 26 | F | 58 | 1218 | 427 | 37 | 3 | 6 | 1 | 0 | 2 | Exon 5 | delC16340 | Minus 1fs |
20 | 21 | M | 272 | 318 | 418 | 37 | 1 | 4 | 16 | 1 | 1 | Intron 3 | C15805A | (ivs3 −8sa) insPQ94 |
21 | 1 | F | 0 | 1243 | 501 | 29 | 3 | 2 | 15 | 9 | 12 | Intron 4 | G16073A | (ivs4 +1sd)del V161-F170 |
22 | 33 | M | 124 | 990 | 235 | 45 | 6 | 6 | 4 | 0 | 0 | Intron 4 | G16077A | (ivs4 +5sd)del V161-F170 |
23 | 20 | M | 0 | 1449 | 413 | 34 | 3 | 9 | 13 | 3 | 0 | no mutation | ||
24 | 50 | M | 199 | 39 | 150 | 44 | 0 | 2 | 2 | 0 | 1 | no mutation | ||
25 | 14 | M | 330 | 465 | 281 | 37 | Not done | no mutation | ||||||
Mean | 14 | 112 | 1489 | 415 | 35 | 1 | 7 | 9 | 3 | 2 | ||||
SE | 2 | 21 | 227 | 31 | 1 | 0 | 1 | 2 | 1 | 1 | ||||
1-aNormal data | ||||||||||||||
Mean | 3563 | 571 | 242 | 43 | 1 | 3 | 11 | 11 | 25 | |||||
SE | 171 | 49 | 9 | 1 | 0 | 0 | 1 | 0 | 1 |
Subject . | Age (y) . | Gender . | ANC1-1/ mm1-3 . | AMC1-2/ mm1-3 . | Platelets1-3× 101-3/mm1-3 . | HCT1-4% . | Bone marrow evaluations1-5 . | Elastase mutations . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mblast % . | Promyelo % . | Myelo % . | Meta % . | B/Poly % . | Exon/intron . | Nucleotide1-6 . | Effect on protein1-7 . | |||||||
1 | 4 | M | 0 | 2943 | 558 | 36 | Severe maturation arrest | Exon 2 | G34010A | A28T | ||||
2 | 13 | M | 0 | 1891 | 348 | 32 | 2 | 5 | 23 | 7 | 2 | Exon 2 | T34020C | I31T |
3 | 15 | F | 106 | 1484 | 349 | 36 | 0 | 6 | 0 | 0 | 1 | Exon 2 | T34052A | C42S |
4 | 3 | F | 97 | 2928 | 547 | 30 | Arrest at myelocyte, very few mature neutrophils | Exon 3 | G34371A | V72M | ||||
5 | 8 | F | 126 | 1071 | 513 | 27 | 0 | 5 | 7 | 0 | 0 | Exon 3 | G34371A | V72M |
6 | 11 | M | 0 | 5372 | 576 | 29 | 0 | 7 | 1 | 0 | 1 | Exon 4 | C15823T | S97L |
7 | 3 | F | 79 | 2196 | 546 | 30 | 0 | 2 | 7 | 2 | 0 | Exon 4 | C15862T | P110L |
8 | 15 | F | 159 | 599 | 403 | 37 | 0 | 21 | 19 | 0 | 0 | Exon 4 | C15862T | P110L |
9 | 25 | M | 215 | 320 | 214 | 39 | 3 | 8 | 21 | 11 | 4 | Exon 4 | C15862T | P110L |
10 | 33 | F | 220 | 740 | 227 | 32 | 0 | 4 | 6 | 2 | 4 | Exon 4 | C15862T | P110L |
11 | 14 | M | 96 | 1088 | 320 | 25 | 3 | 11 | 2 | 0 | 0 | Exon 4 | ins5T16063 | delV161-F170 +2fs |
12 | 18 | F | 33 | 990 | 483 | 36 | 0 | 10 | 1 | 2 | 0 | Exon 4 | del15995-16018 | delV145-C152 |
13 | 4 | F | 0 | 3943 | 639 | 43 | Not done | Exon 5 | G16268T | G181V | ||||
14 | 10 | F | 0 | 1610 | 650 | 34 | 0 | 9 | 0 | 0 | 0 | Exon 5 | G16279A | G185R |
15 | 0.4 | M | 34 | 3041 | 272 | 39 | 3 | 1 | 1 | 0 | 1 | Exon 5 | G16300T | G192Stop |
16 | 4 | M | 318 | 504 | 534 | 35 | 1 | 10 | 26 | 15 | 6 | Exon 5 | C16313A | S196Stop |
17 | 3 | F | 200 | 4300 | 722 | 26 | Not done | Exon 5 | C16323A | Y199Stop | ||||
18 | 5 | M | 0 | 1797 | 345 | 34 | Not done | Exon 5 | delC16324 | Minus 1fs | ||||
19 | 26 | F | 58 | 1218 | 427 | 37 | 3 | 6 | 1 | 0 | 2 | Exon 5 | delC16340 | Minus 1fs |
20 | 21 | M | 272 | 318 | 418 | 37 | 1 | 4 | 16 | 1 | 1 | Intron 3 | C15805A | (ivs3 −8sa) insPQ94 |
21 | 1 | F | 0 | 1243 | 501 | 29 | 3 | 2 | 15 | 9 | 12 | Intron 4 | G16073A | (ivs4 +1sd)del V161-F170 |
22 | 33 | M | 124 | 990 | 235 | 45 | 6 | 6 | 4 | 0 | 0 | Intron 4 | G16077A | (ivs4 +5sd)del V161-F170 |
23 | 20 | M | 0 | 1449 | 413 | 34 | 3 | 9 | 13 | 3 | 0 | no mutation | ||
24 | 50 | M | 199 | 39 | 150 | 44 | 0 | 2 | 2 | 0 | 1 | no mutation | ||
25 | 14 | M | 330 | 465 | 281 | 37 | Not done | no mutation | ||||||
Mean | 14 | 112 | 1489 | 415 | 35 | 1 | 7 | 9 | 3 | 2 | ||||
SE | 2 | 21 | 227 | 31 | 1 | 0 | 1 | 2 | 1 | 1 | ||||
1-aNormal data | ||||||||||||||
Mean | 3563 | 571 | 242 | 43 | 1 | 3 | 11 | 11 | 25 | |||||
SE | 171 | 49 | 9 | 1 | 0 | 0 | 1 | 0 | 1 |
Healthy volunteers = 39 subjects—21 males and 18 females.
ANC = Absolute neutrophil count. Measurement is the median of baseline counts.
AMC = Absolute monocyte count. Measurement is the median of baseline counts.
Measurement is the median of baseline counts.
Measurement is the median of baseline counts.
Mblast indicates myeloblast; Promyelo, promyelocyte; Myelo, Myelocyte; Meta, metamyelocyte; B/Polys, bands + polymorphonuclear cells.
Position of nucleotides for subjects 1-5 (mutations in exon 1-3) corresponds to GenBank AC004799 and for subjects 6-21 (mutations in intron 3-exon 5) to GenBank AC010648.
Numbering of splice site mutations is relative to the intron (negative)/exon (positive) boundary. Amino acid numbering begins from the first amino acid after the presignal peptide cleavage.
ins indicates insertion; del, deletion; ivs, intervening sequence; sa, splice acceptor; sd, splice donor; fs = frame shift.